Loss of PLK2 induces acquired resistance to temozolomide in GBM via activation of notch signaling

Abstract

Loss of PLK2 enhances aggressive biological behavior of GBM through activation of Notch signaling, indicating that PLK2 could be a prognostic biomarker and potential therapeutic target for chemoresistant GBM.